The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C
Tài liệu tham khảo
Aho, 2004, Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser1 12 gatekeeper site, FEBS Lett., 571, 43, 10.1016/j.febslet.2004.06.050
Alevizos, 2001, Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis, Oncogene, 20, 6196, 10.1038/sj.onc.1204685
Allen, 1997, Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc, Oncogene, 15, 1133, 10.1038/sj.onc.1201288
Bachmann, 2004, The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): A novel role for Pim-1 at the G2/M cell cycle checkpoint, J. Biol. Chem., 279, 48319, 10.1074/jbc.M404440200
Bhattacharya, 2002, Pim-1 associates with protein complexes necessary for mitosis, Chromosoma, 111, 80, 10.1007/s00412-002-0192-6
Blomberg, 1999, Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases, Mol. Cell. Biol., 19, 6183, 10.1128/MCB.19.9.6183
Borg, 1999, Prolactin regulation of pim-1 expression: Positive and negative promoter elements, Endocrinology, 140, 5659, 10.1210/en.140.12.5659
Buckley, 1995, Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells, Endocrinology, 136, 5252, 10.1210/en.136.12.5252
Chen, 2002, Pim serine/threonine kinases regulate the stability of Socs-1 protein, Proc. Natl. Acad. Sci. U.S.A., 99, 2175, 10.1073/pnas.042035699
Cuypers, 1984, Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region, Cell, 37, 141, 10.1016/0092-8674(84)90309-X
Dautry, 1988, Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines, J. Biol. Chem., 263, 17615, 10.1016/S0021-9258(19)77880-6
Dhanasekaran, 2001, Delineation of prognostic biomarkers in prostata cancer, Nature, 412, 822, 10.1038/35090585
Domen, 1993, Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells, Blood, 82, 1445, 10.1182/blood.V82.5.1445.1445
Domen, 1993, Analysis of Pim-1 function in mutant mice, Leukemia, 7, 108
Eichmann, 2000, Developmental expression of pim kinases suggests functions also outside of the hematopoietic system, Oncogene, 19, 1215, 10.1038/sj.onc.1203355
Friedmann, 1992, Characterization of the proto-oncogene pim-1: Kinase activity and substrate recognition sequence, Arch. Biochem. Biophys., 298, 594, 10.1016/0003-9861(92)90454-5
Graves, 2001, Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding, Oncogene, 20, 1839, 10.1038/sj.onc.1204259
Hassepass, 2004, Assaying Cdc25 phosphatase activity, Methods Mol. Biol., 281, 153
Ishibashi, 2001, Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus, FEBS Lett., 506, 33, 10.1016/S0014-5793(01)02881-2
Jaster, 1999, Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action, Cell Signal., 11, 769, 10.1016/S0898-6568(99)00050-9
Jaster, 1999, Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells, Cell Signal., 11, 331, 10.1016/S0898-6568(98)00049-7
Koike, 2000, Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1, FEBS Lett., 467, 17, 10.1016/S0014-5793(00)01105-4
Krumenacker, 1998, Prolactin receptor signaling: Shared components with the T-cell antigen receptor in Nb2 lymphoma cells, Endocrine, 9, 163, 10.1385/ENDO:9:2:163
Laird, 1993, In vivo analysis of Pim-1 deficiency, Nucleic Acids Res., 21, 4750, 10.1093/nar/21.20.4750
Leverson, 1998, Pim-1 kinase and p100 cooperate to enhance c-Myb activity, Mol. Cell., 2, 417, 10.1016/S1097-2765(00)80141-0
Lilly, 1997, Enforced expression of the Mr 33 000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells, Cancer Res., 57, 5348
Lilly, 1999, The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway, Oncogene, 18, 4022, 10.1038/sj.onc.1202741
Maita, 2000, PAP-1, a novel target protein of phosphorylation by pim-1 kinase, Eur. J. Biochem., 267, 5168, 10.1046/j.1432-1327.2000.01585.x
Margolis, 2003, PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation, EMBO J., 22, 5734, 10.1093/emboj/cdg545
Matikainen, 1999, Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells, Blood, 93, 1980, 10.1182/blood.V93.6.1980.406k20_1980_1991
Mochizuki, 1999, Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase Implications for the Pim-1-mediated activation of the c-Myc signalling pathway, J. Biol. Chem., 274, 18659, 10.1074/jbc.274.26.18659
Möröy, 1993, Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice, Proc. Natl. Acad. Sci. U.S.A., 90, 10734, 10.1073/pnas.90.22.10734
Mucenski, 1987, Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains, Oncogene Res., 2, 33
Narimatsu, 2001, Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells, Mol. Cell. Biol., 21, 6615, 10.1128/MCB.21.19.6615-6625.2001
Nosaka, 1999, STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells, EMBO J., 18, 4754, 10.1093/emboj/18.17.4754
Padma, 1991, The human PIM-1 gene product is a protein serine kinase, Cancer Res., 51, 2486
Palaty, 1997, Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase, Biochem. Cell. Biol., 75, 153, 10.1139/o97-026
Palaty, 1997, Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase, J. Biol. Chem., 272, 10514, 10.1074/jbc.272.16.10514
Peltola, 2004, Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3, Blood, 103, 3744, 10.1182/blood-2003-09-3126
Peng, 1998, C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding, Cell Growth Differ., 9, 197
Pircher, 2000, Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death, Oncogene, 19, 3684, 10.1038/sj.onc.1203684
Qian, 2001, The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes, Mol. Biol. Cell., 12, 1791, 10.1091/mbc.12.6.1791
Rainio, 2002, Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase, J. Immunol., 168, 1524, 10.4049/jimmunol.168.4.1524
Roshak, 2000, The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase, Cell Signal., 405, 10.1016/S0898-6568(00)00080-2
Saris, 1991, The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG, EMBO J., 10, 655, 10.1002/j.1460-2075.1991.tb07994.x
Selten, 1985, Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas, EMBO J., 4, 1793, 10.1002/j.1460-2075.1985.tb03852.x
Shirogane, 1999, Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis, Immunity, 11, 709, 10.1016/S1074-7613(00)80145-4
Takizawa, 2000, Control of mitosis by changes in the subcellular location of cyclin-B 1-Cdk1 and Cdc25C, Curr. Opin. Cell. Biol., 12, 658, 10.1016/S0955-0674(00)00149-6
van der Lugt, 1995, Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2, EMBO J., 14, 2536, 10.1002/j.1460-2075.1995.tb07251.x
van Lohuizen, 1989, Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors, Cell, 56, 673, 10.1016/0092-8674(89)90589-8
Wang, 2001, Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells, Arch. Biochem. Biophys., 39, 9, 10.1006/abbi.2001.2370
Wang, 2002, Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase, Biochim. Biophys. Acta, 1593, 45, 10.1016/S0167-4889(02)00347-6
Winn, 2003, Pim-1 phosphorylates the DNA binding domain of c-Myb, Cell Cycle, 2, 258, 10.4161/cc.2.3.383
Yan, 2003, The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death, J. Biol. Chem., 278, 45358, 10.1074/jbc.M307933200
Zörnig, 1996, Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2, Oncogene, 12, 1789